Ciproxifan maleate

TargetMol
Product Code: TAR-T2004
Supplier: TargetMol
CodeSizePrice
TAR-T2004-1mg1mg£99.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2004-2mg2mg£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2004-5mg5mg£129.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2004-1mL1 mL * 10 mM (in DMSO)£134.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2004-10mg10mg£157.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2004-25mg25mg£253.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2004-50mg50mg£410.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T2004-100mg100mg£574.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Ciproxifan maleate(FUB-359 maleate) is a highly potent and selective histamin H3-receptor antagonist with IC50 of 9.2 nM, with low apparent affinity at other receptor subtypes.
CAS:
184025-19-2
Formula:
C20H22N2O6
Molecular Weight:
386.404
Pathway:
GPCR/G Protein; Immunology/Inflammation; Neuroscience
Purity:
0.9945
SMILES:
OC(=O)C=C/C(O)=O.O=C(C1CC1)c1ccc(OCCCc2c[nH]cn2)cc1
Target:
Histamine Receptor

References

1. Ligneau X, et al. J Pharmacol Exp Ther, 1998, 287(2), 658-666. 2. Pillot C, et al. J Neurosci, 2002, 22(16), 7272-7280. 3. Browman KE, et al. Behav Brain Res, 2004, 153(1), 69-76. 4. Bardgett ME, et al. Neurobiol Learn Mem, 2011, 95(1), 64-72. 5. Day M, et al. Biochem Pharmacol, 2007, 73(8), 1123-1134. 6. Xie L, Wu Q, Hu W, et al. Impact of histaminergic H3 receptor antagonist on hypoglossal nucleus in chronic intermittent hypoxia conditions[J]. Psychopharmacology. 2020: 1-11.